(Q45866351)

17 December 2017

title

AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency (English)

1 reference

17 December 2017

author

Marc Bartoli

1

1 reference

17 December 2017

author name string

Poupiot J

2

1 reference

17 December 2017

Vulin A

3

1 reference

17 December 2017

Fougerousse F

4

1 reference

17 December 2017

Arandel L

5

1 reference

17 December 2017

Daniele N

6

1 reference

17 December 2017

Roudaut C

7

1 reference

17 December 2017

Noulet F

8

1 reference

17 December 2017

Garcia L

9

1 reference

17 December 2017

Danos O

10

1 reference

17 December 2017

Richard I

11

1 reference

17 December 2017

publication date

1 March 2007

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

page(s)

733-740

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302928

exact match

0 references

cites work

A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Double muscling in cattle due to mutations in the myostatin gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

A deletion in the myostatin gene causes the compact (Cmpt) hypermuscular mutation in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Myostatin mutation associated with gross muscle hypertrophy in a child

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Dominant negative myostatin produces hypertrophy without hyperplasia in muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Expression of myostatin pro domain results in muscular transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Inhibition of myostatin in adult mice increases skeletal muscle mass and strength

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Induction of cachexia in mice by systemically administered myostatin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Regulation of muscle mass by myostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Myostatin: a therapeutic target for skeletal muscle wasting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Pharmacological strategies for muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

The new frontier in muscular dystrophy research: booster genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Functional improvement of dystrophic muscle by myostatin blockade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Loss of myostatin attenuates severity of muscular dystrophy in mdx mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Myostatin propeptide-mediated amelioration of dystrophic pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Effects of stress on cattle with hereditary muscular hypertrophy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Calpain 3: a key regulator of the sarcomere?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Molecular and cell biology of the sarcoglycan complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

The sarcoglycan complex in limb-girdle muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Adeno-associated virus pseudotype 5 vector improves gene transfer in arthritic joints

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Femoral intra-arterial injection: a tool to deliver and assess recombinant AAV constructs in rodents whole hind limb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302928

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302928

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017